SUTENT is used to treat GIST (gastrointestinal stromal tumor). This is a rare cancer of the stomach, bowel, or esophagus. SUTENT is used when the medicine Gleevec® (imatinib mesylate) did not stop the cancer from growing or when you cannot take Gleevec.
Gleevec is a registered trademark of Novartis AG.

It’s important to keep track of any symptoms or side effects you have. And to tell
your doctor about them. This guide can help you:
- Create a list of symptoms and side effects. Share the list with your doctor
- Print a weekly tracker. Use it to record when you have symptoms and side effects
This content is currently under temporary construction.